Loxapine Capsule
Product Images NDC 0591-0369

5 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 0591-0369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structurla Formula Of Loxapine, A Dibenzoxazepine Compound, Represents A Subclass Of Tricyclic Antipsychotic Agents, Chemically Distinct From The Thioxanthenes, Butyrophenones, And Phenothiazines. Chemically, It Is 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine. It Is Present As The Succinate Salt. (Loxapine Capsules A072062 A072204 A072205 A072206 1)

The Structurla Formula Of Loxapine, A Dibenzoxazepine Compound, Represents A Subclass Of Tricyclic Antipsychotic Agents, Chemically Distinct From The Thioxanthenes, Butyrophenones, And Phenothiazines. Chemically, It Is 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine. It Is Present As The Succinate Salt. (Loxapine Capsules A072062 A072204 A072205 A072206 1)
Chemical structure diagram of Loxapine base, showing the molecular framework with labeled nitrogen, chlorine, and methyl groups.*
FDA Label Image

Img1 (Loxapine Capsules A072062 A072204 A072205 A072206 2)

Img1 (Loxapine Capsules A072062 A072204 A072205 A072206 2)
Label for Loxapine Capsules, USP, 5 mg strength, in a package of 100 capsules. The label states the capsules contain Loxapine Succinate equivalent to 5 mg Loxapine. It includes storage instructions and manufacturer details: Watson Pharma Private Limited in India and Teva Pharmaceuticals in New Jersey. The label is from Actavis Pharma, Inc.*
FDA Label Image

Img2 (Loxapine Capsules A072062 A072204 A072205 A072206 3)

Img2 (Loxapine Capsules A072062 A072204 A072205 A072206 3)
Label for Loxapine Capsules USP 10 mg, a prescription drug supplied in a package of 100 capsules. The label includes the NDC 0591-0370-01 and states storage instructions (20° to 25°C), dispensing information, and manufacturing details by Watson Pharma Private Limited, India, for Teva Pharmaceuticals. The label features the Teva logo and a barcode.*
FDA Label Image

Img3 (Loxapine Capsules A072062 A072204 A072205 A072206 4)

Img3 (Loxapine Capsules A072062 A072204 A072205 A072206 4)
Loxapine Capsules USP 25 mg label for a bottle containing 100 capsules. The label includes directions for storage, dosage note, and child-resistant container instructions. It lists Loxapine Succinate equivalent to 25 mg Loxapine per capsule. The label shows it is manufactured by Watson Pharma Private Limited in India and distributed by Teva Pharmaceuticals.*
FDA Label Image

Img4 (Loxapine Capsules A072062 A072204 A072205 A072206 5)

Img4 (Loxapine Capsules A072062 A072204 A072205 A072206 5)
Label for Loxapine Capsules USP 50 mg by Actavis Pharma, Inc. The label shows a package containing 100 capsules. It includes storage instructions, manufacturer details listing Watson Pharma Private Limited and Teva Pharmaceuticals, and a barcode. The label emphasizes prescription use only and child-resistant container requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.